| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 02/01/2001 | WO2001006984A2 Small molecules useful in the treatment of inflammatory disease |
| 02/01/2001 | WO2000063215A3 Indazole derivatives, preparation and therapeutic application thereof |
| 02/01/2001 | WO2000054764A3 A method of treating bulimia nervosa and related eating disorders by administration of atypical antipsychotic medications |
| 02/01/2001 | WO2000053742A3 Polynucleotides and proteins encoded thereby |
| 02/01/2001 | WO2000053733A3 Hermansky pudlak syndrome protein-interacting proteins and methods of use thereof |
| 02/01/2001 | WO2000050017A3 Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives for the treatment of cerebral diseases |
| 02/01/2001 | WO2000049043A3 Human lipid-associated proteins |
| 02/01/2001 | WO2000047194A3 METHODS OF TREATING C1s-MEDIATED DISEASES AND CONDITIONS, AND COMPOUNDS AND COMPOSITIONS THEREFOR |
| 02/01/2001 | WO2000043781A3 Growth differentiation factor inhibitors and uses therefor |
| 02/01/2001 | WO2000009668A9 Engraftable human neural stem cells |
| 02/01/2001 | WO1999041376A9 Retinoblastoma protein complexes and retinoblastoma interacting proteins |
| 02/01/2001 | DE19935771A1 Neue Vitamin D-Derivate mit cyclischen Substrukturen in den Seitenketten, Verfahren und Zwischenprodukte zu ihrer Herstellung und die Verwendung zur Herstellung von Arzneimitteln New vitamin D derivatives with cyclic substructures in the side chains, to processes and intermediates for their preparation and to the use for the preparation of medicaments |
| 02/01/2001 | DE19934432A1 Indolderivate Indole derivatives |
| 02/01/2001 | CA2689694A1 Solutions and methods for inhibition of pain, inflammation and cartilage degradation |
| 02/01/2001 | CA2396591A1 Abc transport polynucleotides, polypeptides, and antibodies |
| 02/01/2001 | CA2383690A1 29 human secreted proteins |
| 02/01/2001 | CA2382755A1 Substituted oxoazaheterocyclyl compounds |
| 02/01/2001 | CA2380317A1 Human synthetases |
| 02/01/2001 | CA2380208A1 Tricyclic monosaccharide derivatives useful in treating acute ischemia-induced neurodegeneration |
| 02/01/2001 | CA2380037A1 Vgf polypeptides and methods of treating vgf-related disorders |
| 02/01/2001 | CA2379801A1 Receptors and associated proteins |
| 02/01/2001 | CA2379784A1 Cell cycle and proliferation proteins |
| 02/01/2001 | CA2379395A1 Process for the extraction of valerian root |
| 02/01/2001 | CA2379241A1 Peptides containing n-substituted d-amino acids for preventing beta-strand association |
| 02/01/2001 | CA2378953A1 Methods and compositions for inhibiting polypeptide accumulation associated with neurological disorders |
| 02/01/2001 | CA2378779A1 Peptides containing n-substituted l-amino acids for preventing beta-strand association |
| 02/01/2001 | CA2378462A1 Ppar delta inhibitors for the treatment of cardiovascular diseases |
| 02/01/2001 | CA2376465A1 New vitamin d derivatives with cyclic substructures in the side chains, method and intermediates for their production and their use in the preparation of medicaments |
| 02/01/2001 | CA2375571A1 Human nervous system-associated proteins |
| 01/31/2001 | EP1072680A1 Myostatin regulatory region, nucleotide sequence determination and methods for its use |
| 01/31/2001 | EP1072609A2 Cytoprotective agents comprising prosaposin-related peptides |
| 01/31/2001 | EP1072601A2 4-arylpiperidine derivatives for the treatment of pruritus |
| 01/31/2001 | EP1072592A2 4-arylpiperidine derivatives for the treatment of pruritus |
| 01/31/2001 | EP1072266A1 Thienylazolylalcoxyethanamines, their preparation and their application as medicaments |
| 01/31/2001 | EP1072262A1 Dispersible fluoxetine tablet |
| 01/31/2001 | EP1071750A1 Pns cell lines and methods of use therefor |
| 01/31/2001 | EP1071708A1 Edg family gene, human h218 |
| 01/31/2001 | EP1071707A1 Novel omega conotoxin peptides |
| 01/31/2001 | EP1071701A1 Non-endogenous, constitutively activated human serotonin receptors and small molecule modulators thereof |
| 01/31/2001 | EP1071686A1 Novel heterocyclic compounds |
| 01/31/2001 | EP1071684A1 IMIDAZO 1,2-a]PYRIDINES AS PERIPHERAL BENZODIAZEPINE RECEPTOR BINDING AGENTS |
| 01/31/2001 | EP1071680A1 N,n-disubstituted amides that inhibit the binding of integrins to their receptors |
| 01/31/2001 | EP1071679A1 Novel heterocyclic compounds |
| 01/31/2001 | EP1071671A2 Triazolones with a neuroprotective action |
| 01/31/2001 | EP1071670A1 Novel diphenyl-substituted 5-ring-heterocycles, method for producing them and their use as medicaments |
| 01/31/2001 | EP1071655A1 Cubane derivatives as metabotropic glutamate receptor antagonists and process for their preparation |
| 01/31/2001 | EP1071474A1 Substituted porphyrins |
| 01/31/2001 | EP1071455A1 Terminally-branched polymeric linkers and polymeric conjugates containing the same |
| 01/31/2001 | EP1071445A2 Therapeutic angiogenic factors and methods for their use |
| 01/31/2001 | EP1071440A1 Novel synergistic compositions containing aromatic compounds and terpenoids present in alpinia galanga |
| 01/31/2001 | EP1071433A2 Pharmaceutical composition |
| 01/31/2001 | EP1071426A2 Novel compounds and their use as positive ampa receptor modulators |
| 01/31/2001 | EP1071425A1 Treatment of depression and pharmaceutical preparations therefor |
| 01/31/2001 | EP1071424A1 Composition comprising l-carnitine or an alkanoyl l-carnitine and nadh and/or nadph |
| 01/31/2001 | EP1071422A1 Associations de riluzole et de levodopa pour le traitement de la maladie de parkinson |
| 01/31/2001 | EP1071419A1 Cannabinoids as antioxidants and neuroprotectants |
| 01/31/2001 | EP1071418A2 New treatments for nervous disorders |
| 01/31/2001 | EP1071417A1 Use of cannabinoids as anti-inflammatory agents |
| 01/31/2001 | EP1071414A1 Compounds and methods for treating mitochondria-associated diseases |
| 01/31/2001 | EP0842152B1 N-(4-substituted-benzyl)-2-aminolactam derivatives |
| 01/31/2001 | EP0592583B1 Method for the inhibition of aldh-i useful in the treatment of alcohol dependence or alcohol abuse |
| 01/31/2001 | CN1282322A 1,4-diazacycloheptane derivatives |
| 01/31/2001 | CN1282321A Potassium channel openers |
| 01/31/2001 | CN1282254A Compositions and methods for regulating phagocytosis and ICAM-1 expression |
| 01/31/2001 | CN1282252A Ginkgo biloba leaf extracts with reduced 4'-0-methylpyridoxine and biflavone content |
| 01/31/2001 | CN1282241A New use of local anaesthetics against vascular headaches |
| 01/31/2001 | CN1281852A 三唑及咪唑衍生物 Triazole and imidazole derivatives |
| 01/31/2001 | CN1281724A Yantongzhi medicine for curing tooth-ache |
| 01/31/2001 | CN1281716A Medicine for curing diabetic peripheral neuropathy |
| 01/31/2001 | CN1281697A Multifunctional medicine |
| 01/31/2001 | CN1061350C 2.7-substituted octahydro-pyrrolo (1.2-A) pyrazine derivatives |
| 01/31/2001 | CN1061341C 1-amino-ethylindole-derivatives |
| 01/31/2001 | CN1061264C Pure Chinese medicine for stopping drugs and its prepn. technology |
| 01/31/2001 | CN1061240C Chinese Medicine pill for curing paralysis |
| 01/30/2001 | US6180791 Synthesis of 8-substituted xanthines |
| 01/30/2001 | US6180786 Antagonist for excitory amino acids |
| 01/30/2001 | US6180657 Melatonin derivatives for use in treating desynchronization disorders |
| 01/30/2001 | US6180656 Use of condensated (hetaryl-substituted) 1-benzal-3-pyrazol derivates for treating special diseases of the cardiovascular and the central nervous systems |
| 01/30/2001 | US6180648 Analogs of cocaine |
| 01/30/2001 | US6180647 Gastrointestinal disorders; nervous system disorders |
| 01/30/2001 | US6180645 Antiepilepic agent |
| 01/30/2001 | US6180643 Antagonist of interleukins, tumor necrosis factor |
| 01/30/2001 | US6180637 Therapy for parkinson, alzheimer disease |
| 01/30/2001 | US6180630 Tricyclic pyrazolo-pyridazinone analogues as GAGA-A receptor ligands |
| 01/30/2001 | US6180624 Tachykinin antagonist and an opioid analgesic effective at treating pain or nociception |
| 01/30/2001 | US6180623 Used as analgesics and anti-pruritic agents |
| 01/30/2001 | US6180620 Analgesic methods using synthetic catalysts for the dismutation of superoxide radicals |
| 01/30/2001 | US6180613 AAV-mediated delivery of DNA to cells of the nervous system |
| 01/30/2001 | US6180611 Inhibitors of matrix metalloproteinases and tumor necrosis factor |
| 01/30/2001 | US6180403 Antisense inhibition of tumor necrosis factor alpha converting enzyme (TACE) expression |
| 01/30/2001 | US6180387 Nucleotide sequence coding an enzymatic polypeptide; for the detection of bactericides and batericidal agonist and antagonists which prevent bacterial infection |
| 01/30/2001 | US6180386 DNA sequences coding for the human proteins Tx and Ty related to the interleukin-1beta converting enzyme |
| 01/30/2001 | US6180384 Compounds |
| 01/30/2001 | US6180370 Preparing preferential antibodies; generating nucleotide sequences coding preferential antibodies, expressing nucleotide sequences in transformed cell and recovering preferential antibodies |
| 01/30/2001 | US6180355 Method for diagnosing and treating chronic pelvic pain syndrome |
| 01/30/2001 | CA2313825A1 Myostatin regulatory region, nucleotide sequence determination and methods for its use |
| 01/30/2001 | CA2191352C Quinoline derivatives as tachykinin nk3 receptor antagonists |
| 01/30/2001 | CA2145640C Substituted pyrimidines for control of diabetic complications |
| 01/29/2001 | CA2314682A1 A novel crystalline form of 6-hydroxy-3-(4-[2-(piperidin-1-yl)ethoxy]phenoxy)-2-(4-methoxyphenyl)benzo[b]thiophene hydrochloride |
| 01/25/2001 | WO2001005972A1 Compositions and methods for the treatment of immune related diseases |